Harrow Announces Nashville Expansion
Harrow to Present at Three Investor Conferences in September in New York
B.ライリー・フィナンシャルはハロー(HROW.US)のレーティングを強気に据え置き、目標株価を50ドルに据え置いた
B.ライリー・フィナンシャルのアナリストMayank Mamtaniは$Harrow(HROW.US)$のレーティングを強気に据え置き、目標株価を50ドルに据え置いた。TipRanksのデータによると、このアナリストの最近1年間の的中率は27.7%、平均リターンは-13.8%である。注 TipRanksは、金融アナリストの分析データと、アナリストの的中率および平均リターンに関する情報を提供している
Harrow Is Maintained at Buy by B. Riley Securities
Craig-Hallum Maintains Buy on Harrow, Raises Price Target to $45
Harrow Analyst Ratings
Earnings Call: Harrow Health Reports Record Revenue, Bullish on VEVYE Growth
Harrow Up Over 55%, on Track for Highest Close Since December 2010 -- Data Talk
Top Midday Gainers
Harrow, Inc. (HROW) Q2 2024 Earnings Call Transcript
10 Health Care Stocks Whale Activity In Today's Session
Top Premarket Gainers
10-Q:Q2 2024 四半期報告書
Harrow Q2 2024 Adj. EPS $(0.06) Beats $(0.20) Estimate, Sales $48.939M Beat $42.509M Estimate
Earnings Flash (HROW) HARROW Posts Q2 Loss $-0.06, Vs. Street Est of $-0.11
Harrow 2Q Loss/Shr 18c >HROW
Here Is the Next Potential Market Catalyst
Novaliq Receives Positive CHMP Opinion for Vevizye in Dry Eye Disease
Harrow To Report Second Quarter 2024 Financial Results After Market Close on August 7, 2024
Ionesi Group Offers Reliable Building Services in Harrow, Northwood, and Watford